Hernia mesh has been a quiet corner of mass torts for a while. On August 4, 2026, a federal jury in Boston made it loud again.
Most of the big mesh defendants settled years ago, the headlines moved on, and plenty of firms started asking whether mesh intake was still worth the ad spend. Then the first Covidien bellwether went to a jury, and the answer came back at $88 million.
What happened in the Patterson v. Covidien trial
A federal jury in the District of Massachusetts found that Covidien, a Medtronic subsidiary, failed to adequately warn physicians about the risks of its Symbotex Composite hernia mesh. The jury awarded $77 million to Larry Patterson and $11 million to his wife, Tammy, on her loss of consortium claim.
The facts were straightforward. Patterson, now 61, received the implant during hernia repair surgery in 2017. His attorneys argued that the mesh’s protective collagen coating dissolved much sooner than doctors were led to expect, which let the bare mesh attach to his bowel. He later needed a second surgery to remove the device along with several inches of intestine.
Why this is a record hernia mesh verdict
According to plaintiffs’ counsel, it is the highest compensatory damages award in the roughly 15-year history of U.S. mesh litigation. That includes every hernia mesh trial and the dozens of transvaginal mesh trials that came before it.
It’s also not a one-off. Patterson was the first bellwether tried in the Covidien Hernia Mesh Products Liability Litigation, and Covidien is the last major body of hernia mesh litigation still standing after units of Becton Dickinson and Johnson & Johnson largely settled their cases.
MDL 3029: the case inventory behind the verdict
This is the part firms should pay attention to:
- More than 2,400 lawsuits are consolidated in the federal MDL in Boston
- Roughly 7,450 additional plaintiffs have similar claims pending in Massachusetts state court
- More than 10,000 claims nationwide, according to what Medtronic has told investors
One clear verdict against the only major defendant left changes the math for everyone in that pool.
Verdict, not settlement: what the award doesn’t mean
This is a jury verdict, not a settlement. Some coverage has blurred that line. Medtronic has said it will challenge the award in post-trial motions and on appeal.
No global settlement has been announced in MDL 3029, and this verdict doesn’t set a value for any other claim. Firms telling prospective clients otherwise are setting themselves up for problems.
What the Covidien verdict means for hernia mesh campaigns
Big bellwether verdicts tend to do two things at once. They put settlement pressure on the defendant, and they wake up claimants. People who had Covidien mesh implanted years ago and ignored earlier ads are now seeing “$88 million” in their news feeds. That second effect is short-lived if your intake isn’t ready for it.
Revisit paused mesh intake
If you shelved mesh campaigns, this is a reasonable moment to take another look. Search interest and response rates usually bump after a major verdict, and that window doesn’t stay open long. If you’d rather not rebuild intake from scratch, our mass tort leads programs can run it alongside your existing dockets.
Tighten your case qualifiers
Patterson centered on a specific product and injury pattern: Covidien composite mesh, bowel adhesion, and revision surgery. Screening for manufacturer, implant date, and documented complications will matter far more than raw volume.
Keep claimant messaging accurate
“Record verdict” is fair game. “You could get $88 million” is not. Claimants who understand the case is still on appeal make better long-term clients anyway.
Watch the next bellwether trials
One verdict is a signal. A second or third pointing the same direction is usually when settlement talks get serious, so plan budgets around the trial calendar.
Hernia mesh verdict FAQ
Is the $88 million hernia mesh verdict a settlement?
No. It is a jury verdict. Medtronic has said it will challenge the award through post-trial motions and on appeal, so the amount could be reduced or overturned, and no global settlement has been announced in MDL 3029.
Which hernia mesh product was involved in the verdict?
The case involved Symbotex Composite mesh made by Covidien, a Medtronic subsidiary. The plaintiff argued its collagen barrier dissolved faster than doctors were told, allowing the mesh to attach to his bowel.
How many Covidien hernia mesh lawsuits are pending?
More than 2,400 cases are consolidated in the federal MDL in Boston, with roughly 7,450 more plaintiffs in Massachusetts state court. Medtronic has told investors it faces more than 10,000 claims nationwide.
The bottom line
Hernia mesh isn’t dead. If anything, the Patterson verdict suggests the Covidien litigation is entering its most active stretch. Firms with mesh infrastructure already in place are well positioned. Firms deciding whether to jump back in should lead with a clear screening process, not just a bigger ad budget.
This article is general information, not legal advice. The Patterson verdict is subject to post-trial motions and appeal, and prior results do not guarantee a similar outcome in any other case.
Back to Blog